Id: | acc0743 |
Group: | 2sens |
Protein: | AR |
Gene Symbol: | AR |
Protein Id: | P10275 |
Protein Name: | ANDR_HUMAN |
PTM: | acetylation |
Site: | Lys609 |
Site Sequence: | NDCTIDKFRRKNCPSCRLRKC |
Disease Category: | Cancer |
Disease: | Prostate Cancer |
Disease Subtype: | castration-resistant prostate cancer |
Disease Cellline: | C4-2B |
Disease Info: | |
Drug: | (R)-9b |
Drug Info: | "(R)-9b is a small-molecule inhibitor targeting the tyrosine kinase ACK1 (also known as TNK2), which regulates androgen receptor expression, and has demonstrated efficacy in suppressing the proliferation of prostate, breast, and lung cancer cells in preclinical studies. " |
Effect: | modulate |
Effect Info: | "Oral administration and subcutaneous injection of the ACK1 small-molecule inhibitor (R)-9b can not only inhibit the phosphorylation of AR at Y267 and the subsequent acetylation at K609, but also suppress the growth of enzalutamide-resistant CRPC xenograft tumors in mice." |
Note: | |
Score: | 4.0 |
Pubmed(PMID): | 35704598 |
Sentence Index: | 35704598_7-8 |
Sentence: | "ACK1 kinase-mediated AR Y267 phosphorylation was a prerequisite for AR K609 acetylation, which spawned positive feedback loops at both the transcriptional and posttranslational level that regenerated and sustained high AR and ACK1 expression. Consistent with these findings, oral and subcutaneous treatment with ACK1 small-molecule inhibitor, (R)-9b, not only curbed AR Y267 phosphorylation and subsequent K609 acetylation but also compromised enzalutamide-resistant CRPC xenograft tumor growth in mice." |
Sequence & Structure:
MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ
Select PDB:
Target | Drug name | MOA | Phase | Status | Disease | Source |
---|---|---|---|---|---|---|
AR | ENZALUTAMIDE | Androgen Receptor antagonist | 4 | Unknown status | metastatic prostate cancer | ClinicalTrials |
AR | FLUTAMIDE | Androgen Receptor antagonist | 4 | - | carcinoma | DailyMed |
AR | BICALUTAMIDE | Androgen Receptor antagonist | 4 | - | carcinoma | DailyMed |
AR | ENZALUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | TESTOSTERONE ENANTHATE | Androgen Receptor agonist | 4 | - | neoplasm | DailyMed DailyMed |
AR | TESTOSTERONE CYPIONATE | Androgen Receptor agonist | 4 | - | neoplasm | DailyMed |
AR | TESTOSTERONE UNDECANOATE | Androgen Receptor agonist | 4 | - | neoplasm | DailyMed DailyMed |
AR | NILUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | FLUOXYMESTERONE | Androgen Receptor agonist | 4 | - | neoplasm | DailyMed |
AR | DAROLUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | BICALUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | ABIRATERONE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | APALUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | TESTOSTERONE | Androgen Receptor agonist | 4 | - | neoplasm | DailyMed DailyMed DailyMed |
AR | ENZALUTAMIDE | Androgen Receptor antagonist | 4 | Completed | prostate adenocarcinoma | ClinicalTrials |
AR | FLUTAMIDE | Androgen Receptor antagonist | 4 | - | neoplasm | ATC |
AR | FLUTAMIDE | Androgen Receptor antagonist | 4 | Recruiting | prostate adenocarcinoma | ClinicalTrials |
AR | APALUTAMIDE | Androgen Receptor antagonist | 4 | Active, not recruiting | prostate adenocarcinoma | ClinicalTrials |
AR | DANAZOL | Androgen Receptor agonist | 4 | - | endometriosis | DailyMed DailyMed |
AR | FLUTAMIDE | Androgen Receptor antagonist | 4 | - | prostate carcinoma | DailyMed DailyMed |
AR | ENZALUTAMIDE | Androgen Receptor antagonist | 4 | - | prostate carcinoma | DailyMed |
AR | APALUTAMIDE | Androgen Receptor antagonist | 4 | - | prostate carcinoma | FDA |
AR | DANAZOL | Androgen Receptor agonist | 4 | - | breast fibrocystic disease | DailyMed |
AR | CLASCOTERONE | Androgen Receptor antagonist | 4 | - | acne | ATC |
AR | CLASCOTERONE | Androgen Receptor antagonist | 4 | Active, not recruiting | acne | ClinicalTrials ClinicalTrials |
Note: Only show clinically investigational or approved drugs with protein targets.
Protein Tractability:
source: Open TargetsPTM Intensity:
source: CPTACNo intensity data of this site,
show all other sites!
AARS-Lys231 | |
---|---|
Cancer | Intensity |
BRCA | 0.58 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.628 |
HNSC | |
LUAD | -1.041 |
LUSC | 1.089 |
non_ccRCC | |
PDAC | |
UCEC |
AARS-Lys338 | |
---|---|
Cancer | Intensity |
BRCA | -1.356 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.056 |
HNSC | |
LUAD | 0.181 |
LUSC | 0.119 |
non_ccRCC | |
PDAC | |
UCEC |
AARS-Lys558 | |
---|---|
Cancer | Intensity |
BRCA | 0.308 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.118 |
HNSC | |
LUAD | |
LUSC | 0.809 |
non_ccRCC | |
PDAC | |
UCEC |
AARS-Lys625 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
AARS-Lys780 | |
---|---|
Cancer | Intensity |
BRCA | -0.034 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.983 |
LUSC | 1.016 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys200 | |
---|---|
Cancer | Intensity |
BRCA | 0.221 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.871 |
HNSC | |
LUAD | |
LUSC | -1.092 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys269 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys370 | |
---|---|
Cancer | Intensity |
BRCA | -1.628 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.774 |
HNSC | |
LUAD | 0.866 |
LUSC | 0.017 |
non_ccRCC | |
PDAC | |
UCEC | -0.029 |
ADAR-Lys374 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys383 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys450 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys503 | |
---|---|
Cancer | Intensity |
BRCA | 0.552 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.154 |
HNSC | |
LUAD | |
LUSC | 0.602 |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys607 | |
---|---|
Cancer | Intensity |
BRCA | -0.534 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.033 |
HNSC | |
LUAD | -0.416 |
LUSC | 1.495 |
non_ccRCC | |
PDAC | |
UCEC | 0.489 |
ADAR-Lys634 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ADAR-Lys820 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
ADAR-Lys871 | |
---|---|
Cancer | Intensity |
BRCA | -1.133 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.758 |
LUSC | 0.375 |
non_ccRCC | |
PDAC | |
UCEC |
ARAP1-Lys1032 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys14 | |
---|---|
Cancer | Intensity |
BRCA | -0.525 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.683 |
HNSC | |
LUAD | -0.929 |
LUSC | -0.136 |
non_ccRCC | |
PDAC | |
UCEC | -0.093 |
ARCN1-Lys142 | |
---|---|
Cancer | Intensity |
BRCA | -0.194 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.083 |
HNSC | |
LUAD | |
LUSC | -0.889 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys241 | |
---|---|
Cancer | Intensity |
BRCA | -0.342 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.477 |
HNSC | |
LUAD | -0.397 |
LUSC | -0.738 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys281 | |
---|---|
Cancer | Intensity |
BRCA | -1.005 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.01 |
LUSC | 0.995 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys309 | |
---|---|
Cancer | Intensity |
BRCA | -0.45 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.376 |
HNSC | |
LUAD | -1.425 |
LUSC | 0.25 |
non_ccRCC | |
PDAC | |
UCEC | 1.25 |
ARCN1-Lys322 | |
---|---|
Cancer | Intensity |
BRCA | 0.659 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.658 |
HNSC | |
LUAD | |
LUSC | -1.033 |
non_ccRCC | |
PDAC | |
UCEC | 1.032 |
ARCN1-Lys323 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys335 | |
---|---|
Cancer | Intensity |
BRCA | 0.343 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.132 |
HNSC | |
LUAD | -0.566 |
LUSC | -1.421 |
non_ccRCC | |
PDAC | |
UCEC | 0.511 |
ARCN1-Lys336 | |
---|---|
Cancer | Intensity |
BRCA | 0.602 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -1.154 |
LUSC | 0.553 |
non_ccRCC | |
PDAC | |
UCEC |
ARCN1-Lys347 | |
---|---|
Cancer | Intensity |
BRCA | 0.774 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.716 |
LUSC | -1.001 |
non_ccRCC | |
PDAC | |
UCEC | 0.942 |
ARCN1-Lys351 | |
---|---|
Cancer | Intensity |
BRCA | -0.363 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.597 |
HNSC | |
LUAD | 0.609 |
LUSC | 0.54 |
non_ccRCC | |
PDAC | |
UCEC | 0.81 |
ARCN1-Lys363 | |
---|---|
Cancer | Intensity |
BRCA | 0.113 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.465 |
HNSC | |
LUAD | |
LUSC | -0.988 |
non_ccRCC | |
PDAC | |
UCEC | 1.34 |
ARCN1-Lys485 | |
---|---|
Cancer | Intensity |
BRCA | -0.095 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.424 |
LUSC | 1.416 |
non_ccRCC | |
PDAC | |
UCEC | -0.898 |
ARF1-Lys142 | |
---|---|
Cancer | Intensity |
BRCA | -0.159 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.886 |
HNSC | |
LUAD | -1.176 |
LUSC | -0.699 |
non_ccRCC | |
PDAC | |
UCEC | 1.148 |
ARF1-Lys36 | |
---|---|
Cancer | Intensity |
BRCA | 0.15 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.388 |
HNSC | |
LUAD | 0.675 |
LUSC | 0.542 |
non_ccRCC | |
PDAC | |
UCEC | -1.754 |
ARF4-Lys109 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARF4-Lys142 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.707 |
ARF4-Lys36 | |
---|---|
Cancer | Intensity |
BRCA | 0.15 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.388 |
HNSC | |
LUAD | 0.675 |
LUSC | 0.542 |
non_ccRCC | |
PDAC | |
UCEC | -1.754 |
ARF5-Lys36 | |
---|---|
Cancer | Intensity |
BRCA | -1.281 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.225 |
HNSC | |
LUAD | 1.047 |
LUSC | 0.459 |
non_ccRCC | |
PDAC | |
UCEC |
ARF6-Lys131 | |
---|---|
Cancer | Intensity |
BRCA | -0.886 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.131 |
HNSC | |
LUAD | -0.594 |
LUSC | 1.047 |
non_ccRCC | |
PDAC | |
UCEC | -0.698 |
ARF6-Lys138 | |
---|---|
Cancer | Intensity |
BRCA | -1.176 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.117 |
HNSC | |
LUAD | 0.459 |
LUSC | -0.4 |
non_ccRCC | |
PDAC | |
UCEC |
ARF6-Lys32 | |
---|---|
Cancer | Intensity |
BRCA | 0.15 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.388 |
HNSC | |
LUAD | 0.675 |
LUSC | 0.542 |
non_ccRCC | |
PDAC | |
UCEC | -1.754 |
ARF6-Lys69 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARF6-Lys7 | |
---|---|
Cancer | Intensity |
BRCA | 0.823 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.289 |
LUSC | -1.113 |
non_ccRCC | |
PDAC | |
UCEC |
ARFGAP1-Lys231 | |
---|---|
Cancer | Intensity |
BRCA | -1.129 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.775 |
LUSC | 0.353 |
non_ccRCC | |
PDAC | |
UCEC |
ARFGAP3-Lys454 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARFIP1-Lys139 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARFIP1-Lys290 | |
---|---|
Cancer | Intensity |
BRCA | 0.986 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.027 |
LUSC | -1.013 |
non_ccRCC | |
PDAC | |
UCEC |
ARGLU1-Lys124 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
ARHGAP1-Lys212 | |
---|---|
Cancer | Intensity |
BRCA | 0.954 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.354 |
HNSC | |
LUAD | 0.497 |
LUSC | -0.096 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGAP1-Lys59 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARHGAP1-Lys80 | |
---|---|
Cancer | Intensity |
BRCA | 0.68 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.862 |
HNSC | |
LUAD | -0.219 |
LUSC | -1.322 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGAP17-Lys48 | |
---|---|
Cancer | Intensity |
BRCA | -1.09 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.215 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 0.875 |
ARHGDIA-Lys105 | |
---|---|
Cancer | Intensity |
BRCA | 0.211 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.114 |
HNSC | |
LUAD | -1.627 |
LUSC | 0.258 |
non_ccRCC | |
PDAC | |
UCEC | 0.045 |
ARHGDIA-Lys127 | |
---|---|
Cancer | Intensity |
BRCA | -0.458 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.201 |
HNSC | |
LUAD | 0.5 |
LUSC | -1.439 |
non_ccRCC | |
PDAC | |
UCEC | 1.196 |
ARHGDIA-Lys141 | |
---|---|
Cancer | Intensity |
BRCA | 0.025 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.628 |
HNSC | |
LUAD | -0.034 |
LUSC | 0.751 |
non_ccRCC | |
PDAC | |
UCEC | 0.886 |
ARHGDIA-Lys178 | |
---|---|
Cancer | Intensity |
BRCA | -1.344 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.98 |
HNSC | |
LUAD | -0.208 |
LUSC | -0.431 |
non_ccRCC | |
PDAC | |
UCEC | 1.003 |
ARHGDIA-Lys43 | |
---|---|
Cancer | Intensity |
BRCA | -0.026 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.19 |
HNSC | |
LUAD | 1.35 |
LUSC | 0.546 |
non_ccRCC | |
PDAC | |
UCEC | -0.68 |
ARHGDIA-Lys50 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys102 | |
---|---|
Cancer | Intensity |
BRCA | -1.149 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.48 |
LUSC | 0.67 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys114 | |
---|---|
Cancer | Intensity |
BRCA | 1.134 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.377 |
LUSC | -0.757 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys124 | |
---|---|
Cancer | Intensity |
BRCA | -0.496 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.667 |
HNSC | |
LUAD | -0.05 |
LUSC | -0.976 |
non_ccRCC | |
PDAC | |
UCEC | -0.144 |
ARHGDIB-Lys135 | |
---|---|
Cancer | Intensity |
BRCA | 0.31 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.777 |
HNSC | |
LUAD | -1.672 |
LUSC | 0.702 |
non_ccRCC | |
PDAC | |
UCEC | -0.117 |
ARHGDIB-Lys138 | |
---|---|
Cancer | Intensity |
BRCA | -0.963 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.135 |
LUSC | 1.339 |
non_ccRCC | |
PDAC | |
UCEC | -0.512 |
ARHGDIB-Lys175 | |
---|---|
Cancer | Intensity |
BRCA | -1.239 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.455 |
HNSC | |
LUAD | -0.499 |
LUSC | -0.031 |
non_ccRCC | |
PDAC | |
UCEC | 0.314 |
ARHGDIB-Lys183 | |
---|---|
Cancer | Intensity |
BRCA | 0.234 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.939 |
HNSC | |
LUAD | 1.305 |
LUSC | -0.6 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys21 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys25 | |
---|---|
Cancer | Intensity |
BRCA | -0.077 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.979 |
HNSC | |
LUAD | 0.567 |
LUSC | -1.639 |
non_ccRCC | |
PDAC | |
UCEC | 0.171 |
ARHGDIB-Lys30 | |
---|---|
Cancer | Intensity |
BRCA | -1.223 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.516 |
HNSC | |
LUAD | -0.332 |
LUSC | -0.198 |
non_ccRCC | |
PDAC | |
UCEC | 0.236 |
ARHGDIB-Lys33 | |
---|---|
Cancer | Intensity |
BRCA | 0.386 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.75 |
LUSC | -1.135 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys40 | |
---|---|
Cancer | Intensity |
BRCA | 1.184 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.822 |
HNSC | |
LUAD | 0.474 |
LUSC | -0.836 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGDIB-Lys47 | |
---|---|
Cancer | Intensity |
BRCA | 0.999 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.835 |
HNSC | |
LUAD | 0.721 |
LUSC | -0.885 |
non_ccRCC | |
PDAC | |
UCEC |
ARHGEF10-Lys556 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARHGEF2-Lys799 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARHGEF7-Lys715 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARID1A-Lys1007 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1A-Lys1612 | |
---|---|
Cancer | Intensity |
BRCA | -0.8 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.321 |
HNSC | |
LUAD | |
LUSC | 1.121 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1A-Lys1819 | |
---|---|
Cancer | Intensity |
BRCA | -1.144 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.425 |
LUSC | 0.411 |
non_ccRCC | |
PDAC | |
UCEC | 1.158 |
ARID1A-Lys1830 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1A-Lys1880 | |
---|---|
Cancer | Intensity |
BRCA | -0.734 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.338 |
HNSC | |
LUAD | -1.21 |
LUSC | 0.412 |
non_ccRCC | |
PDAC | |
UCEC | 0.194 |
ARID1A-Lys1905 | |
---|---|
Cancer | Intensity |
BRCA | -0.432 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.498 |
HNSC | |
LUAD | -0.562 |
LUSC | -0.504 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1A-Lys1953 | |
---|---|
Cancer | Intensity |
BRCA | -1.164 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.723 |
HNSC | |
LUAD | -0.158 |
LUSC | 1.078 |
non_ccRCC | |
PDAC | |
UCEC | 0.968 |
ARID1A-Lys250 | |
---|---|
Cancer | Intensity |
BRCA | -0.471 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.788 |
HNSC | |
LUAD | -0.474 |
LUSC | -0.411 |
non_ccRCC | |
PDAC | |
UCEC | -0.432 |
ARID1A-Lys980 | |
---|---|
Cancer | Intensity |
BRCA | -1.391 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.584 |
HNSC | |
LUAD | 0.353 |
LUSC | 0.436 |
non_ccRCC | |
PDAC | |
UCEC | 1.187 |
ARID1B-Lys1016 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1B-Lys1030 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.516 |
HNSC | |
LUAD | -0.846 |
LUSC | -0.059 |
non_ccRCC | |
PDAC | |
UCEC | 1.42 |
ARID1B-Lys1096 | |
---|---|
Cancer | Intensity |
BRCA | -0.946 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.68 |
HNSC | |
LUAD | -0.423 |
LUSC | 0.009 |
non_ccRCC | |
PDAC | |
UCEC | -0.32 |
ARID1B-Lys1619 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID1B-Lys1823 | |
---|---|
Cancer | Intensity |
BRCA | -0.697 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 1.146 |
non_ccRCC | |
PDAC | |
UCEC | -0.449 |
ARID1B-Lys1951 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.707 |
HNSC | |
LUAD | |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARID1B-Lys1957 | |
---|---|
Cancer | Intensity |
BRCA | -1.115 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.74 |
HNSC | |
LUAD | 0.628 |
LUSC | -0.115 |
non_ccRCC | |
PDAC | |
UCEC | 1.342 |
ARID1B-Lys2163 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID2-Lys1241 | |
---|---|
Cancer | Intensity |
BRCA | -0.991 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.691 |
HNSC | |
LUAD | |
LUSC | -0.714 |
non_ccRCC | |
PDAC | |
UCEC | 1.014 |
ARID4A-Lys1099 | |
---|---|
Cancer | Intensity |
BRCA | -1.07 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.968 |
LUSC | -0.625 |
non_ccRCC | |
PDAC | |
UCEC | 0.727 |
ARID4A-Lys867 | |
---|---|
Cancer | Intensity |
BRCA | -0.254 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.425 |
LUSC | 1.085 |
non_ccRCC | |
PDAC | |
UCEC | -1.256 |
ARID4B-Lys1117 | |
---|---|
Cancer | Intensity |
BRCA | 1.285 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.404 |
HNSC | |
LUAD | -1.349 |
LUSC | -0.123 |
non_ccRCC | |
PDAC | |
UCEC | 0.591 |
ARID4B-Lys1183 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARID4B-Lys1193 | |
---|---|
Cancer | Intensity |
BRCA | -0.734 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.016 |
HNSC | |
LUAD | -0.293 |
LUSC | 1.381 |
non_ccRCC | |
PDAC | |
UCEC | 0.661 |
ARID4B-Lys424 | |
---|---|
Cancer | Intensity |
BRCA | -0.984 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.031 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC | 1.015 |
ARID4B-Lys904 | |
---|---|
Cancer | Intensity |
BRCA | -0.738 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.181 |
HNSC | |
LUAD | -0.096 |
LUSC | -0.697 |
non_ccRCC | |
PDAC | |
UCEC | 1.711 |
ARIH1-Lys142 | |
---|---|
Cancer | Intensity |
BRCA | -0.843 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.262 |
LUSC | 1.105 |
non_ccRCC | |
PDAC | |
UCEC |
ARIH1-Lys522 | |
---|---|
Cancer | Intensity |
BRCA | -0.6 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.555 |
LUSC | 1.154 |
non_ccRCC | |
PDAC | |
UCEC |
ARL1-Lys157 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARL3-Lys62 | |
---|---|
Cancer | Intensity |
BRCA | 0.107 |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.595 |
HNSC | |
LUAD | 1.122 |
LUSC | -0.315 |
non_ccRCC | |
PDAC | |
UCEC | -1.509 |
ARL6IP1-Lys159 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.707 |
HNSC | |
LUAD | |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARL8B-Lys117 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARL8B-Lys141 | |
---|---|
Cancer | Intensity |
BRCA | 0.066 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.349 |
HNSC | |
LUAD | 1.332 |
LUSC | -1.049 |
non_ccRCC | |
PDAC | |
UCEC |
ARL8B-Lys146 | |
---|---|
Cancer | Intensity |
BRCA | 0.415 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -1.141 |
LUSC | 0.726 |
non_ccRCC | |
PDAC | |
UCEC |
ARMT1-Lys178 | |
---|---|
Cancer | Intensity |
BRCA | 0.629 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.153 |
HNSC | |
LUAD | 0.524 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARMT1-Lys56 | |
---|---|
Cancer | Intensity |
BRCA | -1.573 |
COAD | |
HGSC | |
ccRCC | |
GBM | -0.317 |
HNSC | |
LUAD | 1.026 |
LUSC | 0.414 |
non_ccRCC | |
PDAC | |
UCEC | 0.449 |
ARMT1-Lys73 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARNT-Lys119 | |
---|---|
Cancer | Intensity |
BRCA | -0.996 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 1.387 |
LUSC | -0.136 |
non_ccRCC | |
PDAC | |
UCEC | -0.256 |
ARNT-Lys49 | |
---|---|
Cancer | Intensity |
BRCA | -0.246 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -1.216 |
LUSC | 1.173 |
non_ccRCC | |
PDAC | |
UCEC | 0.288 |
ARNT-Lys645 | |
---|---|
Cancer | Intensity |
BRCA | -1.468 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.386 |
LUSC | 0.778 |
non_ccRCC | |
PDAC | |
UCEC | 0.304 |
ARNTL-Lys493 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | 0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARNTL-Lys537 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.707 |
LUSC | -0.707 |
non_ccRCC | |
PDAC | |
UCEC |
ARPC1A-Lys165 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARPC1A-Lys179 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.024 |
HNSC | |
LUAD | |
LUSC | -0.974 |
non_ccRCC | |
PDAC | |
UCEC | -0.05 |
ARPC1A-Lys328 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARPC1A-Lys342 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.109 |
HNSC | |
LUAD | |
LUSC | 0.276 |
non_ccRCC | |
PDAC | |
UCEC | 0.833 |
ARPC1A-Lys36 | |
---|---|
Cancer | Intensity |
BRCA | |
COAD | |
HGSC | |
ccRCC | |
GBM | 0.242 |
HNSC | |
LUAD | |
LUSC | 0.857 |
non_ccRCC | |
PDAC | |
UCEC | -1.099 |
ARPC1A-Lys89 | |
---|---|
Cancer | Intensity |
BRCA | 0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARPC1B-Lys174 | |
---|---|
Cancer | Intensity |
BRCA | 0.376 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.297 |
LUSC | 0.791 |
non_ccRCC | |
PDAC | |
UCEC | -1.464 |
ARPC1B-Lys367 | |
---|---|
Cancer | Intensity |
BRCA | -0.707 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | 0.707 |
LUSC | |
non_ccRCC | |
PDAC | |
UCEC |
ARPC1B-Lys37 | |
---|---|
Cancer | Intensity |
BRCA | -0.733 |
COAD | |
HGSC | |
ccRCC | |
GBM | 1.686 |
HNSC | |
LUAD | -0.336 |
LUSC | 0.091 |
non_ccRCC | |
PDAC | |
UCEC | -0.707 |
ARPC1B-Lys41 | |
---|---|
Cancer | Intensity |
BRCA | 0.152 |
COAD | |
HGSC | |
ccRCC | |
GBM | -1.582 |
HNSC | |
LUAD | 0.717 |
LUSC | 0.951 |
non_ccRCC | |
PDAC | |
UCEC | -0.238 |
ARPC1B-Lys44 | |
---|---|
Cancer | Intensity |
BRCA | 1.143 |
COAD | |
HGSC | |
ccRCC | |
GBM | |
HNSC | |
LUAD | -0.715 |
LUSC | -0.427 |
non_ccRCC | |
PDAC | |
UCEC |